Ribosomal proteins S13 and L23 promote multidrug resistance in gastric cancer cells by suppressing drug-induced apoptosis

• DOI: 10.1016/j.yexcr.2004.02.009
• Publication Date: 2004-03-16T10:24:03Z
• Authors: Yongquan Shi; Huihong Zhai; Xin Wang; Zheyi Han; Changjiang Liu; Mei Lan; Jingping Du; Changcun Guo; Yumei Zhang; Kaichun Wu; Daiming Fan
• Keywords: Ribosomal Proteins; 0301 basic medicine; Apoptosis; Transfection; Drug Resistance, Multiple; Neoplasm Proteins; 3. Good health; 03 medical and health sciences; Proto-Oncogene Proteins c-bcl-2; Stomach Neoplasms; Vincristine; Cell Line, Tumor; Proto-Oncogene Proteins; Humans; Cell Division; Glutathione Transferase; bcl-2-Associated X Protein

Ribosomal proteins (RP) S13 and RPL23 were previously identified as two upregulated genes in a multidrug-resistant gastric cancer cell line SGC7901/VCR compared to its parental cell SGC7901 by differential display PCR. The aim of this study was to explore the roles of RPS13 and RPL23 in multidrug resistance (MDR) in gastric cancer cells. RPS13 and RPL23 were genetically overexpressed in SGC7901 cells, respectively. Either RPS13 or RPL23 enhanced resistance of SGC7901 cells to vincristine, adriamycin, and 5-fludrouracil. RPL23 also enhanced resistance of SGC7901 cells to cisplatin. Overexpression of either RPS13 or RPL23 did not alter the population doubling time, [3H]leucine incorporation, and intracellular adriamycin accumulation of SGC7901 cells. However, either RPS13 or RPL23 could protect SGC7901 cells from undergoing vincristine-induced apoptosis. Western blot analysis revealed that both RPS13 and RPL23 significantly increased the expression level of Bcl-2 and Bcl-2/Bax ratio in SGC7901 cells. In addition, overexpression of RPL23 enhanced glutathione S-transferase (GST) activity and intracellular glutathione content in SGC7901 cells. Together, this work demonstrates that either RPS13 or RPL23 can promote MDR in gastric cancer cells by suppressing drug-induced apoptosis, and that RPL23 may also promote MDR in gastric cancer cells through regulation of glutathione S-transferase-mediated drug-detoxifying system.